1.Mechanism study of chlorogenic acid alleviating macrophage activation
Wei ZHENG ; Jing LANG ; Xifeng HUANG ; Rui XIAO ; He BAI ; Ji JIA
China Pharmacy 2023;34(21):2601-2607
OBJECTIVE To observe the effects of chlorogenic acid on the activation of macrophage induced by lipopolysaccharide (LPS), and to explore the role of triggering receptors expressed on myeloid cells-2 (TREM2) in the action. METHODS To find a suitable LPS concentration, the cells were cultured with 1, 10 and 100 ng/mL LPS for 24 h. The level of interleukin 6 (IL-6) in the cell culture supernatant and protein expression of inducible nitric oxide synthase (iNOS) in the cells were detected. To search for a suitable chlorogenic acid concentration, the cells were divided into control group, LPS group and three chlorogenic acid (0.01, 0.1 and 1 μmol/L)+LPS groups. The levels of tumor necrosis factor α (TNF-α) and IL-1β in the cell culture supernatant, the protein expressions of iNOS and TREM2 in the cells and cell viability were detected. To observe the effects of TREM2 in chlorogenic acid alleviating macrophage activation, TREM2-small interfering RNA (TREM2-siRNA) was taken to intervene in TREM2 protein expression. The cells were divided into control group, LPS group, chlorogenic acid+LPS group, TREM2-siRNA+chlorogenic acid+LPS group and SC-siRNA+chlorogenic acid+LPS group. After 24 h incubation, the levels of TNF- α and IL-1β in the cell culture supernatant and protein expressions of TREM2, iNOS and nuclear factor κB p65 (NF-κB p65) in the cells were detected. RESULTS 10 ng/mL LPS promoted IL-6 release and increased iNOS protein expression, and 10 ng/mL LPS was taken in the next experiments. Compared with the LPS group, 0.1 μmol/L chlorogenic acid decreased TNF-α jiaji1981@126.com and IL-1β levels, and down-regulated iNOS expression,meanwhile increased TREM2 expression without effect on cell viability, and 0.1 μmol/L chlorogenic acid was taken in the next experiments. Compared with the control group, the protein expressions of iNOS and NF- κB p65 in the LPS group were significantly increased (P<0.05); compared with the LPS group, the protein expressions of iNOS and NF- κB p65 in the chlorogenic acid+LPS group were significantly decreased, the protein expressions of TREM2 was significantly increased (P< 0.05); compared with the chlorogenic acid+LPS group, the protein expressions of iNOS and NF-κB p65 of TREM2-siRNA+ chlorogenic acid+LPS group were significantly increased, the protein expressions of TREM2 was significantly decreased (P<0.05). TREM2-siRNA could significantly reverse the above effects of chlorogenic acid, while SC-siRNA did not significantly affect the above anti-inflammatory effects of chlorogenic acid. CONCLUSIONS Chlorogenic acid can inhibit the LPS-induced macrophage activation, and its anti-inflammatory may be mediated by TREM2 protein.
2.Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Xiao-dong HUANG ; Jun-lin YI ; Li GAO ; Guo-zhen XU ; Jing JIN ; Wei-zhi YANG ; Tai-xiang LU ; Shao-xiong WU ; Ren-rui WU ; Wei-han HU ; Wei-chang XIE ; Fei HAN ; Yuan-hong GAO ; Jian-ming GAO ; Jian-ji PAN ; Chuan-ben CHEN ; Jin-yi LANG ; Tao LI ; Yu DONG ; Yu-bing FU ; Lin FAN ; Bo-sen LI ; Jing LI ; Xiao-huai WANG ; Bing-xu CHEN ; Xian-shu GAO ; Ping ZHANG ; Xiang-wei WU ; Bing-qiang HU
Chinese Journal of Oncology 2007;29(3):197-201
OBJECTIVETo evaluate the efficacy and safty of the humanized anti-epidermal factor receptor monoclonal antibody h-R3 in combination with radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
METHODSTotally, 137 patients from 7 medical center around China were randomly divided into combined therapy group or control group. There was no difference in Karnofsky performance score between two groups. All patients in both groups received radical conventionally fractionated radiotherapy to the total dose of D(T) 70-76 Gy. For the combined therapy group, h-R3 was added at a dose of 100 mg i.v. weekly for 8 weeks started at the beginning of radiotherapy.
RESULTSOf the 137 eligilbe patients, 70 were in the combined therapy group treated by h-R3 plus radiotherapy and 67 in the control group by radiotherapy alone. The intent-to-treat (ITT) population consisted of 130 patients, while the per-protocol (PP) population was composed of 126 patients. The efficacy was assessed respectively at three point of time: the end of treatment, the 5th- and 17th-week after treatment. The complete response (CR) of the combined therapy group was significantly higher than that of the control group in both ITT and PP (ITT: 65.63%, 87.50%, 90.63% versus 27.27%, 42.42%, 51.52%; PP: 67.21%, 90.16%, 93.44% versus 27.69%, 43.08%, 52.31%; P < 0.05, respectively). The most common h-R3-related adverse reactions were fever (4.3%), hypotension (2.9%), nausea (1.4%), dizziness (2.9%) and rash (1.4%), which could be reversible if treated properly. Radiotherapy combined with 100 mg h-R3 i. v. weekly was tolerable and did not aggravate the side effects of radiation. The quality of life in the combined therapy group was comparable to that in the control group.
CONCLUSIONThis phase 1 multicenter clinical trial shows that h-R3 in combination with radiotherapy is effective and well-tolerated for the treatment of locoregionally advanced nasopharyngeal carcinoma.
Adult ; Aged ; Antibodies, Monoclonal ; adverse effects ; therapeutic use ; Carcinoma, Squamous Cell ; pathology ; therapy ; Combined Modality Therapy ; Female ; Fever ; etiology ; Humans ; Hypotension ; etiology ; Male ; Middle Aged ; Nasopharyngeal Neoplasms ; pathology ; therapy ; Neoplasm Staging ; Quality of Life ; Radiotherapy ; adverse effects ; methods ; Receptor, Epidermal Growth Factor ; immunology ; Remission Induction
3.Accuracy and capability of tri-ponderal mass index in assessing cardio-metabolic risk factors in Chinese children and adolescents aged 3 to 17 years, compared with body mass index.
Rui CHEN ; Lang JI ; Lijuan MA ; Yitong CHEN ; Jiali DUAN ; Mingjing MA ; Ying SUN ; Jun TAI ; Linghui MENG
Chinese Medical Journal 2023;136(11):1339-1348
BACKGROUND:
Tri-ponderal mass index (TMI) has been reported to be a more accurate estimate of body fat than body mass index (BMI). This study aims to compare the effectiveness of TMI and BMI in identifying hypertension, dyslipidemia, impaired fasting glucose (IFG), abdominal obesity, and clustered cardio-metabolic risk factors (CMRFs) in 3- to 17-year-old children.
METHODS:
A total of 1587 children aged 3 to 17 years were included. Logistic regression was used to evaluate correlations between BMI and TMI. Area under the curves (AUCs) were used to compare discriminative capability among indicators. BMI was converted to BMI- z scores, and accuracy was compared by false-positive rate, false-negative rate, and total misclassification rate.
RESULTS:
Among children aged 3 to 17 years, the mean TMI was 13.57 ± 2.50 kg/m 3 for boys and 13.3 ± 2.33 kg/m 3 for girls. Odds ratios (ORs) of TMI for hypertension, dyslipidemia, abdominal obesity, and clustered CMRFs ranged from 1.13 to 3.15, higher than BMI, whose ORs ranged from 1.08 to 2.98. AUCs showed similar ability of TMI (AUC: 0.83) and BMI (AUC: 0.85) in identifying clustered CMRFs. For abdominal obesity and hypertension, the AUC of TMI was 0.92 and 0.64, respectively, which was significantly better than that of BMI, 0.85 and 0.61. AUCs of TMI for dyslipidemia and IFG were 0.58 and 0.49. When 85th and 95th of TMI were set as thresholds, total misclassification rates of TMI for clustered CMRFs ranged from 6.5% to 16.4%, which was not significantly different from that of BMI- z scores standardized according to World Health Organization criteria.
CONCLUSIONS
TMI was found to have equal or even better effectiveness in comparison with BMI in identifying hypertension, abdominal obesity, and clustered CMRFs TMI was more stable than BMI in 3- to 17-year-old children, while it failed to identify dyslipidemia and IFG. It is worth considering the use of TMI for screening CMRFs in children and adolescents.
Adolescent
;
Child
;
Child, Preschool
;
Female
;
Humans
;
Male
;
Body Mass Index
;
Dyslipidemias
;
East Asian People
;
Hypertension
;
Obesity, Abdominal
;
Pediatric Obesity/diagnosis*
;
Cardiometabolic Risk Factors
4.Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κ B-ROS/NLRP3 Pathway.
Jing YI ; Li LI ; Zhu-Jun YIN ; Yun-Yun QUAN ; Rui-Rong TAN ; Shi-Long CHEN ; Ji-Rui LANG ; Jiao LI ; Jin ZENG ; Yong LI ; Zi-Jian SUN ; Jun-Ning ZHAO
Chinese journal of integrative medicine 2023;29(10):895-904
OBJECTIVE:
To examine the anti-inflammatory effects and potential mechanisms of polypeptide from Moschus (PPM) in lipopolysaccharide (LPS)-induced THP-1 macrophages and BALB/c mice.
METHODS:
The polypeptide was extracted from Moschus and analyzed by high-performance liquid chromatography and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Subsequently, LPS was used to induce inflammation in THP-1 macrophages and BALB/c mice. In LPS-treated or untreated THP-1 macrophages, cell viability was observed by cell counting kit 8 and lactate dehydrogenase release assays; the proinflammatory cytokines and reactive oxygen species (ROS) were measured by enzyme-linked immunosorbent assay and flow cytometry, respectively; and protein and mRNA levels were measured by Western blot and real-time quantitative polymerase chain reaction (qRT-PCR), respectively. In LPS-induced BALB/c mice, the proinflammatory cytokines were measured, and lung histology and cytokines were observed by hematoxylin and eosin (HE) and immunohistochemical (IHC) staining, respectively.
RESULTS:
The SDS-PAGE results suggested that the molecular weight of purified PPM was in the range of 10-26 kD. In vitro, PPM reduced the production of interleukin 1β (IL-1β), IL-18, tumor necrosis factor α (TNF-α), IL-6 and ROS in LPS-induced THP-1 macrophages (P<0.01). Western blot analysis demonstrated that PPM inhibited LPS-induced nuclear factor κB (NF-κB) pathway and thioredoxin interacting protein (TXNIP)/nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain containing 3 (NLRP3) inflammasome pathway by reducing protein expression of phospho-NF-κB p65, phospho-inhibitors of NF-κB (Iκ Bs) kinase α/β (IKKα/β), TXNIP, NLRP3, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), and pro-caspase-1 (P<0.05 or P<0.01). In addition, qRT-PCR revealed the inhibitory effects of PPM on the mRNA levels of TXNIP, NLRP3, ASC, and caspase-1 (P<0.05 or P<0.01). Furthermore, in LPS-induced BALB/c mice, PPM reduced TNF-α and IL-6 levels in serum (P<0.05 or P<0.01), decreased IL-1β and IL-18 levels in the lungs (P<0.01) and alleviated pathological injury to the lungs.
CONCLUSION
PPM could attenuate LPS-induced inflammation by inhibiting the NF-κB-ROS/NLRP3 pathway, and may be a novel potential candidate drug for treating inflammation and inflammation-related diseases.
5.Transmission risk of patients with COVID-19 meeting discharge criteria should be interpreted with caution.
Jun-Wei SU ; Wen-Rui WU ; Guan-Jing LANG ; Hong ZHAO ; Ji-Fang SHENG
Journal of Zhejiang University. Science. B 2020;21(5):408-410
As of Apr. 22, 2020, the World Health Organization (2020) has reported over 2.4 million confirmed coronavirus disease 2019 (COVID-19) patients and 169 151 deaths. Recent articles have uncovered genomic characteristics and clinical features of COVID-19 (Chan et al., 2020; Chang et al., 2020; Guan et al., 2020; Zhu et al., 2020), while our understanding of COVID-19 is still limited. As suggested by guidelines promoted by the General Office of National Health Commission of the People's Republic of China (2020) (from Versions 1 to 6), discharged standards for COVID-19 were still dependent on viral real-time polymerase chain reaction (RT-PCR) tests of respiratory specimens, showing that recovered COVID-19 patients with twice negative RT-PCR could meet discharge criteria. Here, we examined two cases in which nucleic acid test results were inconsistent with clinical and radiological findings, leading to suboptimal care.
Adult
;
Betacoronavirus
;
China
;
Clinical Laboratory Techniques
;
Coronavirus Infections
;
diagnosis
;
transmission
;
Female
;
Humans
;
Male
;
Middle Aged
;
Pandemics
;
Patient Discharge
;
Pneumonia, Viral
;
diagnosis
;
transmission
;
Real-Time Polymerase Chain Reaction
;
Reverse Transcriptase Polymerase Chain Reaction
;
Sputum
;
virology